Are Revived Infusions Safe
Data from Phase 2 trials (Jastreboff et al., NEJM 2023) provide the most detailed safety information currently available, though it is important to recognise that longer-term safety data from Phase 3 trials are still being gathered
Optic Labs supplies retatrutide as a high-purity lyophilised powder in 5mg, 10mg, 15mg, 20mg and 30mg vials, packaged for in vitro and preclinical laboratory research
In 2026, the clinical landscape has changed
Meeting highlights from the PRAC 2326 October 2023 GLP-1 receptor agonists: available evidence not supporting link with thyroid cancer
For reference, the FDA label dose of tesamorelin alone is 2 mg/day (legacy formulation) or 1.28 mg/day for the newer EGRIFTA WR formulation, and ipamorelin has been studied at roughly 100-300 mcg per dose in research settings